These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

206 related articles for article (PubMed ID: 35390488)

  • 1. Red blood cell-hitchhiking mediated pulmonary delivery of ivermectin: Effects of nanoparticle properties.
    Zheng J; Lu C; Ding Y; Zhang J; Tan F; Liu J; Yang G; Wang Y; Li Z; Yang M; Yang Y; Gong W; Gao C
    Int J Pharm; 2022 May; 619():121719. PubMed ID: 35390488
    [TBL] [Abstract][Full Text] [Related]  

  • 2. RBC-hitchhiking chitosan nanoparticles loading methylprednisolone for lung-targeting delivery.
    Ding Y; Lv B; Zheng J; Lu C; Liu J; Lei Y; Yang M; Wang Y; Li Z; Yang Y; Gong W; Han J; Gao C
    J Control Release; 2022 Jan; 341():702-715. PubMed ID: 34933051
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A remodeled ivermectin polycaprolactone-based nanoparticles for inhalation as a promising treatment of pulmonary inflammatory diseases.
    Mohammed SW; El-Megrab NA; Hasan AA; Gomaa E
    Eur J Pharm Sci; 2024 Apr; 195():106714. PubMed ID: 38301972
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Red Blood Cell Hitchhiking: A Novel Approach for Vascular Delivery of Nanocarriers.
    Brenner JS; Mitragotri S; Muzykantov VR
    Annu Rev Biomed Eng; 2021 Jul; 23():225-248. PubMed ID: 33788581
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Repositioning Ivermectin for Covid-19 treatment: Molecular mechanisms of action against SARS-CoV-2 replication.
    Low ZY; Yip AJW; Lal SK
    Biochim Biophys Acta Mol Basis Dis; 2022 Feb; 1868(2):166294. PubMed ID: 34687900
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Nanoparticle-based drug delivery via RBC-hitchhiking for the inhibition of lung metastases growth.
    Zelepukin IV; Yaremenko AV; Shipunova VO; Babenyshev AV; Balalaeva IV; Nikitin PI; Deyev SM; Nikitin MP
    Nanoscale; 2019 Jan; 11(4):1636-1646. PubMed ID: 30644955
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Red Blood Cell-Hitchhiking Delivery of Simvastatin to Relieve Acute Respiratory Distress Syndrome.
    Sun M; Wei J; Su Y; He Y; Ge L; Shen Y; Xu B; Bi Y; Zheng C
    Int J Nanomedicine; 2024; 19():5317-5333. PubMed ID: 38859953
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Attenuation of clinical and immunological outcomes during SARS-CoV-2 infection by ivermectin.
    de Melo GD; Lazarini F; Larrous F; Feige L; Kornobis E; Levallois S; Marchio A; Kergoat L; Hardy D; Cokelaer T; Pineau P; Lecuit M; Lledo PM; Changeux JP; Bourhy H
    EMBO Mol Med; 2021 Aug; 13(8):e14122. PubMed ID: 34170074
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A nanotechnological approach in the current therapy of COVID-19: model drug oseltamivir-phosphate loaded PLGA nanoparticles targeted with spike protein binder peptide of SARS-CoV-2.
    Ucar B; Acar T; Arayici PP; Derman S
    Nanotechnology; 2021 Sep; 32(48):. PubMed ID: 34375967
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Red blood cell-hitchhiking chitosan nanoparticles for prolonged blood circulation time of vitamin K
    Wang Y; Zhou C; Ding Y; Liu M; Tai Z; Jin Q; Yang Y; Li Z; Yang M; Gong W; Gao C
    Int J Pharm; 2021 Jan; 592():120084. PubMed ID: 33188893
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Delivering nanoparticles to lungs while avoiding liver and spleen through adsorption on red blood cells.
    Anselmo AC; Gupta V; Zern BJ; Pan D; Zakrewsky M; Muzykantov V; Mitragotri S
    ACS Nano; 2013 Dec; 7(12):11129-37. PubMed ID: 24182189
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Inhaled route and anti-inflammatory action of ivermectin: Do they hold promise in fighting against COVID-19?
    Mittal N; Mittal R
    Med Hypotheses; 2021 Jan; 146():110364. PubMed ID: 33246694
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Repurposing Potential of the Antiparasitic Agent Ivermectin for the Treatment and/or Prophylaxis of COVID-19.
    Awad H; Hassan B; Dweek S; Aboelata Y; Rawas-Qalaji M; Ahmed IS
    Pharmaceuticals (Basel); 2022 Aug; 15(9):. PubMed ID: 36145289
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Treatment of bleomycin-induced pulmonary fibrosis by inhaled tacrolimus-loaded chitosan-coated poly(lactic-co-glycolic acid) nanoparticles.
    Lee C; Seo J; Hwang HS; Thao LQ; Lee S; Lee ES; Lee EH; Choi HG; Youn YS
    Biomed Pharmacother; 2016 Mar; 78():226-233. PubMed ID: 26898446
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Preferential tumor accumulation and desirable interstitial penetration of poly(lactic-co-glycolic acid) nanoparticles with dual coating of chitosan oligosaccharide and polyethylene glycol-poly(D,L-lactic acid).
    Wang G; Chen Y; Wang P; Wang Y; Hong H; Li Y; Qian J; Yuan Y; Yu B; Liu C
    Acta Biomater; 2016 Jan; 29():248-260. PubMed ID: 26476340
    [TBL] [Abstract][Full Text] [Related]  

  • 16. An
    Azam F; Taban IM; Eid EEM; Iqbal M; Alam O; Khan S; Mahmood D; Anwar MJ; Khalilullah H; Khan MU
    J Biomol Struct Dyn; 2022 Apr; 40(6):2851-2864. PubMed ID: 33131430
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Modularity of RBC hitchhiking with polymeric nanoparticles: testing the limits of non-covalent adsorption.
    Lenders V; Escudero R; Koutsoumpou X; Armengol Álvarez L; Rozenski J; Soenen SJ; Zhao Z; Mitragotri S; Baatsen P; Allegaert K; Toelen J; Manshian BB
    J Nanobiotechnology; 2022 Jul; 20(1):333. PubMed ID: 35842697
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Safety and Pharmacokinetic Assessments of a Novel Ivermectin Nasal Spray Formulation in a Pig Model.
    Errecalde J; Lifschitz A; Vecchioli G; Ceballos L; Errecalde F; Ballent M; Marín G; Daniele M; Turic E; Spitzer E; Toneguzzo F; Gold S; Krolewiecki A; Alvarez L; Lanusse C
    J Pharm Sci; 2021 Jun; 110(6):2501-2507. PubMed ID: 33493479
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Long-acting inhalable chitosan-coated poly(lactic-co-glycolic acid) nanoparticles containing hydrophobically modified exendin-4 for treating type 2 diabetes.
    Lee C; Choi JS; Kim I; Oh KT; Lee ES; Park ES; Lee KC; Youn YS
    Int J Nanomedicine; 2013; 8():2975-83. PubMed ID: 23976850
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Anti-COVID property of subcutaneous ivermectin in synergy with zinc among midlife moderately symptomatic patients: a structured summary of a study protocol for a randomised controlled trial.
    Ashraf S; Ashraf S; Farooq I; Ashraf S; Ashraf M; Imran MA; Kalsoom L; Akmal R; Ghufran M; Rafique S; Akram MK; Habib Z; Siddiqui UN; Ahmad A; Arshad S; Virk MAR; Gul M; Awais AB; Hassan M; Sherazi SSH; Safdar Z; Munir I; Khalid H; Munir K; Majeed N; Alahmadi YM; Humayun A; Saboor QA; Ahmad A; Ashraf M; Izhar M;
    Trials; 2021 Sep; 22(1):591. PubMed ID: 34488858
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.